
    
      The purpose of this research study is to evaluate a new blood test as a way to follow the
      effect of Zometa in treating bone metastases. The blood test will look for a protein, called
      TRAP, which is released into the blood stream by the breakdown of bone. This study will
      compare the TRAP blood test with other blood tests for bone destruction.
    
  